Use the code BLOG10 to get 10% off
These peptides are not weight-loss medications and shouldnt be compared to GLP-1 drugs like semaglutide or tirzepatide
2 CONCLUSION: GLP-1R agonists have the potential, at least in theory, to regulate platelet activation directly through the effect on platelet function and indirectly through the control of body weight and metabolism
Intestinal Obstruction and Bowel Injuries: Some GLP-1 users have also reported bowel obstructions, intestinal blockages, and, in the most severe cases, colon rupture
This trial led the FDA to expand Wegovy's label to include reducing cardiovascular risk in people with obesity
Kanna was a huge success in our pre-workout formula because it also complements stimulants very well, which you have probably found out first hand if you have tried Gorilla Mode